VBI Vaccines
VBIV
#10529
Rank
HK$14.56 M
Marketcap
HK$0.51
Share price
0.00%
Change (1 day)
-89.29%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): -HK$79.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -HK$78.88. In 2022 the company made an earnings per share (EPS) of -HK$102.68 a decrease over its 2021 EPS that were of -HK$63.01.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$79.49
2022-HK$102.6862.96%
2021-HK$63.0128.57%
2020-HK$49.01-54.35%
2019-HK$107.35-52.58%
2018-HK$226.3710.23%
2017-HK$205.3714.29%
2016-HK$179.69-62.8%
2015-HK$483.0790.68%
2014-HK$253.35-7.95%
2013-HK$275.24-57.97%
2012-HK$654.93-78%
2011-HK$2,9773151.47%
2010-HK$91.5723.87%
2009-HK$73.93-18.48%
2008-HK$90.6912.08%
2007-HK$80.92-49.47%
2006-HK$160.14
2005N/A-100%
2004-HK$71.1911.94%
2003-HK$63.60-81.89%
2002-HK$351.17196.44%
2001-HK$118.4684.33%
2000-HK$64.27-65.37%
1999-HK$185.58-29.45%
1998-HK$263.0429.61%
1997-HK$202.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.39-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$33.68-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-HK$28.55-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA